Pre-Movers Stocks In Imitation: Anthera Pharmaceuticals (NASDAQ:ANTH), Fitbit, Inc. (NYSE:FIT)

Shares of Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) [Trend Analysis] swings enthusiastically in regular trading session, it an increase of 38.10% to close at $2.03. The Anthera Pharmaceuticals Inc. (ANTH) BOD released J. Craig Thompson has been promoted to Chief Executive Officer. Mr. Thompson has also been appointed to serve as a member of the Board of Directors of the Company. Paul Truex has stepped down from the CEO role and been appointed to the newly created role of Executive Chairman, where he will assume the responsibilities of the Chairman of the Board and continue to provide guidance to Anthera’s senior executive team.

Concurrent with the leadership transition, Dr. Christopher Henney has stepped down as Chairman of the Board after more than 10 years of service to the Company in this role but will remain a member of Anthera’s Board of Directors. “The addition of Craig at the beginning of this year has allowed the Company to incorporate commercial readiness planning into our development efforts. Over the past twelve months Craig has proven his ability to lead and to fully integrate his experiences into the operation of Anthera,” continued Mr. Truex. “His appointment prepares us for the commercialization of Sollpura and continued development of blisibimod for IgA nephropathy. I am confident Anthera will continue to thrive with the expansion of Craig’s leadership.” Moving forward to saw long-term intention, the experts calculate Return on Investment of -88.80%. The stock is going forward its fifty-two week low with 52.63% and lagging behind from its 52-week high price with -60.89%. ANTH last month stock price volatility remained 11.37%.

Fitbit, Inc. (NYSE:FIT) [Trend Analysis] retains strong position in active trade, as shares scoring -0.13% to $7.97 in a active trade session, while looking at the shares volume, around 8.43 Million shares have changed hands in this session. Fitbit to Cancel Pebble Time 2, Pebble Core Upon Acquisition and Refund Backers: Report .Last week, it was declared that Fitbit is looking to buy Pebble for as little as $40 million. Now, a fresh report sheds light on more details of the deal, and it looks like the Pebble Time 2 and Pebble Core will never hit the market if this deal comes through.

According to Bloomberg, this Fitbit and Pebble deal is ‘imminent’ and that only 40 percent of the employees will be retained – mostly software engineers. This testifies further to Fitbit’s plans to just acquire the software business, and let go off the hardware and products line. Furthermore, the report states that the Pebble Time 2 and Pebble Core smartwatches will be cancelled, and the money will be refunded to the crowdfunding backers. The smartwatches were crowdfunded on Kickstarter, and the Pebble Time 2 managed to raise $13 million. The firm has institutional ownership of 79.00%, while insider ownership included 22.41%. FIT attains analyst recommendation of 2.90 with week’s performance of -4.67%. Investors looking further ahead will note that the Price to next year’s EPS is 14.09%.


About Blake Escott

Blake Escott holds junior writer position in SWR. Before joining Streetwise Report, he was a freelance content Writer. He has high-level copywriting experience and particularly experienced in proofreading and editing. He covers news about different companies including all US market sectors. Interests: Commodities, Energy stocks, Sector-wise Stocks analysis, Utilities

Leave a Reply

Your email address will not be published. Required fields are marked *